TSE:FFH

Fairfax Financial (FFH.TO)

2,326.80
+5.86 (0.25%)
as of Jul 15, 2026, 8:00:00 pm Market Open.
281 watching
0
Investor Insights
star iconJul 15, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Fairfax Financial (FFH-T) is viewed as a solid and well-managed company with a good long-term growth outlook, although the sentiment around it currently appears mixed. While some experts highlight its strong earnings and improved underwriting performance, especially in the context of Q4 results, others suggest that the stock lacks momentum and potential catalysts for short-term growth. The valuation appears reasonable, but not particularly cheap, with much of the easy money already made. Multiple experts believe the stock is at a crossroads, with some viewing it as a decent long-term hold while others recommend being cautious and potentially reallocating investment to better opportunities. Overall, FFH-T's performance may hinge significantly on the company's ability to execute on acquisitions and sustain growth in the competitive insurance space.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
HOLD

He owns this for a long while and did well. He sold it in October when its relative strength weakened. The stock has since bounced off $2,200, but this looks like a sideways trading range with resistance at $2,400-2,500. Insurance struggled this year, but FFH did the least.

BUY

Stay with this long term. Their India business has potential. The stock is not followed well, because of its high stock price.

BUY ON WEAKNESS

In the defensive part of Canadian financial services. Underwriting profitability consistently getting better, the core reason why stock's been doing better. Opportunity to term out its fixed income portfolio. Not a screaming bargain today, but makes sense as part of a diversified portfolio especially as we pivot away from banks and get a bit more defensive.

BUY

Continues to be encouraged by what company's doing. Low double-digit PE, undemanding. Modest dividend so they can keep capital and grow their portfolio.

PARTIAL SELL

Buying back shares. Much more disciplined on investments than previously. Trading at highest valuation seen in quite some time. He's been taking $$ off the table.

PARTIAL SELL

Insurance sector's been behaving well over last 3 years. Trimmed about a month ago. Prefers capital markets banks at the moment, but nothing wrong with this name.

HOLD

Has done extremely well. If you own it, hold. He's just never had the time to fully research it. People he respects and who own it say to buy, buy, buy. 

BUY ON WEAKNESS

He's been in and out of this one and probably should have just stayed in. Really good company. Trend is good. If you own, definitely hold. Has probably arced off the trendline a bit, so it'll probably pull back a bit and you can buy more.

BUY

Very successful. P&C is a bit easier to understand than life insurance, which tends to be rate-sensitive and has investment risk.

WAIT

Wonderful company, his favourite in the group. Has owned in past, but not now due to valuation. Near record highs. P&C insurance is very defensive, so it draws crowds when people get panicky in the market and the price gets bid up. Wait for a better valuation.

HOLD

A bit of a black box. Stock price has done very well the last few years, after having gone nowhere before that. Insurance at the core, and Prem Watsa's done a great job allocating those premiums. Higher rates favours insurers, lower rates the opposite, and he has no control over what the future holds.

If you own it, hold. You may want to investigate succession plans.

BUY

Everyone was shorting it in the 2000s, and now it's one of the most favoured stocks on the TSX. Up 13% YTD. He owns it in TFSAs. Helped by global acquisitions. Combined ratio ~94%. Underwriting has improved, costs kept in line. Almost every operation it has is showing profitability.

Estimated PE for this year is about 10x, normal for insurance industry. Has hit a high, but it's one you want to own for the long term. He continues to buy for clients.

premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK

FFH will keep chugging along under fine management, improving combined ratios and pure momentum. Bay Street is flashing buy signals and an 11% price target to $2,600. The main drawback with Fairfax is its share price, currently above $2,300. Don't expect a stock split anytime soon. However, if your pockets are deep and your horizon is long, then FFH is right for you.

BUY

Great job growing book value, and with organic growth and underwriting. EPS profile has really improved. The share price looks "expensive", but it trades at only 7.7x PE for 2026, and growing at 18%. More upside.

Darling in the 1990s, then struggled forever. Great comeback.

BUY

Has done well, and will probably continue to do so. Well positioned in its space. Also does well in an environment of higher long-term yields, whereas many companies (especially those with elevated debt) flounder. A name like this will insulate you from that.